Skip to main content

Advertisement

Log in

Transpupillary thermotherapy for myopic choroidal neovascularization: 1-year follow-up

TTT for myopic CNV

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose To evaluate the use of transpupillary thermotherapy (TTT) for myopic choroidal neovascularization (CNV) retrospectively in a case series.

Methods Ten consecutive patients with CNV secondary to high myopia were treated with TTT and followed-up for 18.3 ± 7.1 months (range: 12–30 months). An activity scoring (AS) scheme based on CNV size, central foveal thickness as determined by optical coherence tomography (OCT), amount of subretinal hemorrhage, and fluorescein angiography (FA) staining characteristics was developed to assess the response to treatment. The main outcome measures were AS and visual acuity (VA).

Results There was no significant loss or gain in VA, and the lesions stabilized in all eyes. FA revealed late staining typical of CNV scarring, and the amount of central foveal thickness decreased in all eyes, as determined by OCT. The mean AS at 3, 6, and 12 months and at the final visit were significantly lower than the preoperative AS (P < 0.05). No complication occurred during or after treatment.

Conclusion A scheme for evaluating overall CNV activity may be useful tool for assessing the response of patients to TTT. TTT seems to stabilize myopic CNVs both clinically and as revealed by angiography, with a significant decrease in the activity of lesions. Longer term results are required to evaluate the stabilizing effect of TTT in myopic CNV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ghafour IM, Allan D, Foulds WS (1983) Common causes of blindness and visual handicap in the West of Scotland. Br J Ophthalmol 67:209–213

    PubMed  CAS  Google Scholar 

  2. Tokoro T (1998) Criteria for diagnosis of pathologic myopia. In: Tokoro T (ed) Atlas of posterior fundus changes in pathologic myopia. Springer, Tokyo, pp 1–2

    Google Scholar 

  3. Sperduto RD, Seigel D, Roberts J, Rowland M (1983) Prevalence of myopia in the United States. Arch Ophthalmol 101:405–407

    PubMed  CAS  Google Scholar 

  4. Green JS, Bear JC, Johnson GJ (1986) The burden of genetically determined eye disease. Br J Ophthalmol 70:696–699

    PubMed  CAS  Google Scholar 

  5. Tabandeh H, Flynn HW Jr, Scott IU et al. (1999) Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 106:2063–2067

    Article  PubMed  CAS  Google Scholar 

  6. Avila MP, Weiter JJ, Jalkh AE et al. (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581

    PubMed  CAS  Google Scholar 

  7. Yoshida T, Ohno-Matsui K, Ohtake Y et al. (2002) Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 109:712–719

    Article  PubMed  Google Scholar 

  8. Yoshida T, Ohno-Matsui K, Yasuzumi K et al. (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110:1297–1305

    Article  PubMed  Google Scholar 

  9. Blinder KJ, Blumenkranz MS, Bressler NM et al (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial – VIP report no. 3. Ophthalmology 110:667–673

    Article  PubMed  Google Scholar 

  10. Reichel E, Berrocal AM, Ip M et al. (1999) Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 106:1908–1914

    Article  PubMed  CAS  Google Scholar 

  11. Newsom RSB, McAlister JC, Saeed M, McHugh JDA (2001) Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularization. Br J Ophthalmol 85:173–178

    Article  PubMed  CAS  Google Scholar 

  12. Reichel E, Musch DC, Blodi BA et al. (2005) Results from the TTT4CNV clinical trial. Invest Ophthalmol Vis Sci, ARVO 2005 E-Abstr 46:2311

  13. Pasechnikova NV, Teslenko AS (2002) Transpupillary thermotherapy of classic choroidal neovascular membranes. Vestn Oftalmol 118:30–32

    PubMed  CAS  Google Scholar 

  14. Mainster MA, Reichel E (2001) Transpupillary thermotherapy for age-related macular degeneration: principles and techniques. Semin Ophthalmol 16:55–59

    Article  PubMed  CAS  Google Scholar 

  15. Jalkh AE, Weiter JJ, Trempe CL et al (1987) Choroidal neovascularization in degenerative myopia: role of laser photocoagulation. Ophthalmic Surg 18:721–725

    PubMed  CAS  Google Scholar 

  16. Ruiz-Moreno JM, Montero JA (2002) Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes. Eur J Ophthamol 12:117–122

    CAS  Google Scholar 

  17. Bottoni F, Perego E, Airaghi P et al (1999) Surgical removal of subfoveal choroidal neovascular membranes in high myopia. Graefes Arch Clin Exp Ophthalmol 237:573–582

    Article  PubMed  CAS  Google Scholar 

  18. Ruiz-Moreno JM, de la Vega C (2001) Surgical removal of subfoveal choroidal neovascularization in highly myopic patients. Br J Ophthalmol 85:1041–1043

    Article  PubMed  CAS  Google Scholar 

  19. Secretan M, Kuhn D, Soubrane G, Coscas G (1997) Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 7:307–316

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmet Hondur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozdek, S., Hondur, A., Gurelik, G. et al. Transpupillary thermotherapy for myopic choroidal neovascularization: 1-year follow-up. Int Ophthalmol 26, 127–133 (2005). https://doi.org/10.1007/s10792-006-9010-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-006-9010-0

Keywords

Navigation